ID   RISA_ECOLI              Reviewed;         213 AA.
AC   P0AFU8; P29015;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   15-MAR-2017, entry version 95.
DE   RecName: Full=Riboflavin synthase;
DE            Short=RS;
DE            EC=2.5.1.9;
GN   Name=ribC; Synonyms=ribE; OrderedLocusNames=b1662, JW1654;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   SUBUNIT.
RC   STRAIN=K12 / RR28;
RX   PubMed=9022701; DOI=10.1111/j.1432-1033.1996.0712r.x;
RA   Eberhardt S.M.R., Richter G., Gimbel W., Werner T., Bacher A.;
RT   "Cloning, sequencing, mapping and hyperexpression of the ribC gene
RT   coding for riboflavin synthase of Escherichia coli.";
RL   Eur. J. Biochem. 242:712-719(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9023191; DOI=10.1128/jb.179.4.1105-1111.1997;
RA   Hensel M., Shea J.E., Baeumler A.J., Gleeson C., Blattner F.R.,
RA   Holden D.W.;
RT   "Analysis of the boundaries of Salmonella pathogenicity island 2 and
RT   the corresponding chromosomal region of Escherichia coli K-12.";
RL   J. Bacteriol. 179:1105-1111(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097039; DOI=10.1093/dnares/3.6.363;
RA   Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K., Itoh T.,
RA   Kasai H., Kashimoto K., Kimura S., Kitakawa M., Kitagawa M.,
RA   Makino K., Miki T., Mizobuchi K., Mori H., Mori T., Motomura K.,
RA   Nakade S., Nakamura Y., Nashimoto H., Nishio Y., Oshima T., Saito N.,
RA   Sampei G., Seki Y., Sivasundaram S., Tagami H., Takeda J.,
RA   Takemoto K., Takeuchi Y., Wada C., Yamamoto Y., Horiuchi T.;
RT   "A 570-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 28.0-40.1 min region on the linkage map.";
RL   DNA Res. 3:363-377(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   STRUCTURE BY NMR OF 1-97 IN COMPLEX WITH RIBOFLAVIN.
RX   PubMed=11399071; DOI=10.1006/jmbi.2001.4683;
RA   Truffault V., Coles M., Diercks T., Abelmann K., Eberhardt S.,
RA   Luttgen H., Bacher A., Kessler H.;
RT   "The solution structure of the N-terminal domain of riboflavin
RT   synthase.";
RL   J. Mol. Biol. 309:949-960(2001).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=11377200; DOI=10.1016/S0969-2126(01)00600-1;
RA   Liao D.I., Wawrzak Z., Calabrese J.C., Viitanen P.V., Jordan D.B.;
RT   "Crystal structure of riboflavin synthase.";
RL   Structure 9:399-408(2001).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 1-97 IN COMPLEX WITH
RP   RIBOFLAVIN.
RX   PubMed=12927541; DOI=10.1016/S0022-2836(03)00844-1;
RA   Meining W., Eberhardt S., Bacher A., Ladenstein R.;
RT   "The structure of the N-terminal domain of riboflavin synthase in
RT   complex with riboflavin at 2.6A resolution.";
RL   J. Mol. Biol. 331:1053-1063(2003).
CC   -!- FUNCTION: Catalyzes the dismutation of two molecules of 6,7-
CC       dimethyl-8-ribityllumazine, resulting in the formation of
CC       riboflavin and 5-amino-6-(D-ribitylamino)uracil.
CC       {ECO:0000269|PubMed:9022701}.
CC   -!- CATALYTIC ACTIVITY: 2 6,7-dimethyl-8-(1-D-ribityl)lumazine =
CC       riboflavin + 4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine.
CC       {ECO:0000269|PubMed:9022701}.
CC   -!- PATHWAY: Cofactor biosynthesis; riboflavin biosynthesis;
CC       riboflavin from 2-hydroxy-3-oxobutyl phosphate and 5-amino-6-(D-
CC       ribitylamino)uracil: step 2/2.
CC   -!- SUBUNIT: Homotrimer. Unlike in B.subtilis, does not interact with
CC       6,7-dimethyl-8-ribityllumazine synthase.
CC       {ECO:0000269|PubMed:11399071, ECO:0000269|PubMed:12927541,
CC       ECO:0000269|PubMed:9022701}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X69109; CAA48861.1; -; Genomic_DNA.
DR   EMBL; U68703; AAB47940.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74734.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15429.1; -; Genomic_DNA.
DR   PIR; S28526; S28526.
DR   RefSeq; NP_416179.1; NC_000913.3.
DR   RefSeq; WP_000493947.1; NZ_LN832404.1.
DR   PDB; 1HZE; NMR; -; A/B=1-97.
DR   PDB; 1I18; NMR; -; A/B=1-97.
DR   PDB; 1I8D; X-ray; 2.00 A; A/B/C=1-213.
DR   PDB; 1PKV; X-ray; 2.60 A; A/B=1-97.
DR   PDBsum; 1HZE; -.
DR   PDBsum; 1I18; -.
DR   PDBsum; 1I8D; -.
DR   PDBsum; 1PKV; -.
DR   ProteinModelPortal; P0AFU8; -.
DR   SMR; P0AFU8; -.
DR   DIP; DIP-47865N; -.
DR   IntAct; P0AFU8; 3.
DR   STRING; 511145.b1662; -.
DR   DrugBank; DB00140; Riboflavin.
DR   SWISS-2DPAGE; P0AFU8; -.
DR   EPD; P0AFU8; -.
DR   PaxDb; P0AFU8; -.
DR   PRIDE; P0AFU8; -.
DR   EnsemblBacteria; AAC74734; AAC74734; b1662.
DR   EnsemblBacteria; BAA15429; BAA15429; BAA15429.
DR   GeneID; 945848; -.
DR   KEGG; ecj:JW1654; -.
DR   KEGG; eco:b1662; -.
DR   PATRIC; 32118630; VBIEscCol129921_1735.
DR   EchoBASE; EB1378; -.
DR   EcoGene; EG11406; ribC.
DR   eggNOG; ENOG4108R6K; Bacteria.
DR   eggNOG; COG0307; LUCA.
DR   HOGENOM; HOG000151758; -.
DR   InParanoid; P0AFU8; -.
DR   KO; K00793; -.
DR   OMA; HILSGHV; -.
DR   PhylomeDB; P0AFU8; -.
DR   BioCyc; EcoCyc:RIBOFLAVIN-SYN-MONOMER; -.
DR   BioCyc; MetaCyc:RIBOFLAVIN-SYN-MONOMER; -.
DR   BRENDA; 2.5.1.9; 2026.
DR   UniPathway; UPA00275; UER00405.
DR   EvolutionaryTrace; P0AFU8; -.
DR   PRO; PR:P0AFU8; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0004746; F:riboflavin synthase activity; IDA:EcoCyc.
DR   GO; GO:0009231; P:riboflavin biosynthetic process; IDA:EcoCyc.
DR   Gene3D; 2.40.30.20; -; 2.
DR   InterPro; IPR023366; ATP_synth_asu-like.
DR   InterPro; IPR001783; Lumazine-bd.
DR   InterPro; IPR026017; Lumazine-bd_dom.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR21098; PTHR21098; 1.
DR   Pfam; PF00677; Lum_binding; 2.
DR   PIRSF; PIRSF000498; Riboflavin_syn_A; 1.
DR   SUPFAM; SSF63380; SSF63380; 2.
DR   TIGRFAMs; TIGR00187; ribE; 1.
DR   PROSITE; PS51177; LUMAZINE_BIND; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Reference proteome; Repeat;
KW   Riboflavin biosynthesis; Transferase.
FT   CHAIN         1    213       Riboflavin synthase.
FT                                /FTId=PRO_0000068166.
FT   REPEAT        1     97       Lumazine-binding 1.
FT   REPEAT       98    195       Lumazine-binding 2.
FT   REGION        4      6       Substrate 1 binding.
FT                                {ECO:0000250|UniProtKB:Q2YN92,
FT                                ECO:0000305|PubMed:12927541}.
FT   REGION       48     50       Substrate 2 binding; shared with one
FT                                trimeric partner.
FT                                {ECO:0000250|UniProtKB:Q2YN92,
FT                                ECO:0000305|PubMed:12927541}.
FT   REGION       62     67       Substrate 2 binding; shared with one
FT                                trimeric partner.
FT                                {ECO:0000250|UniProtKB:Q2YN92,
FT                                ECO:0000305|PubMed:12927541}.
FT   REGION      101    103       Substrate 2 binding; shared with one
FT                                trimeric partner.
FT                                {ECO:0000250|UniProtKB:Q2YN92}.
FT   REGION      146    148       Substrate 1 binding.
FT                                {ECO:0000250|UniProtKB:Q2YN92}.
FT   REGION      160    165       Substrate 1 binding.
FT                                {ECO:0000250|UniProtKB:Q2YN92}.
FT   BINDING     137    137       Substrate 2 binding.
FT                                {ECO:0000250|UniProtKB:Q2YN92}.
FT   STRAND        8     17       {ECO:0000244|PDB:1I8D}.
FT   STRAND       19     27       {ECO:0000244|PDB:1I8D}.
FT   HELIX        30     32       {ECO:0000244|PDB:1I8D}.
FT   STRAND       41     44       {ECO:0000244|PDB:1I8D}.
FT   STRAND       47     55       {ECO:0000244|PDB:1I8D}.
FT   STRAND       58     64       {ECO:0000244|PDB:1I8D}.
FT   HELIX        65     70       {ECO:0000244|PDB:1I8D}.
FT   HELIX        72     75       {ECO:0000244|PDB:1I8D}.
FT   STRAND       81     86       {ECO:0000244|PDB:1I8D}.
FT   STRAND      105    115       {ECO:0000244|PDB:1I8D}.
FT   STRAND      118    126       {ECO:0000244|PDB:1I8D}.
FT   HELIX       128    133       {ECO:0000244|PDB:1I8D}.
FT   STRAND      139    142       {ECO:0000244|PDB:1I8D}.
FT   STRAND      145    148       {ECO:0000244|PDB:1I8D}.
FT   STRAND      154    161       {ECO:0000244|PDB:1I8D}.
FT   HELIX       163    168       {ECO:0000244|PDB:1I8D}.
FT   HELIX       171    173       {ECO:0000244|PDB:1I8D}.
FT   STRAND      179    184       {ECO:0000244|PDB:1I8D}.
FT   HELIX       186    204       {ECO:0000244|PDB:1I8D}.
SQ   SEQUENCE   213 AA;  23445 MW;  CD1C7E40E4AC88B6 CRC64;
     MFTGIVQGTA KLVSIDEKPN FRTHVVELPD HMLDGLETGA SVAHNGCCLT VTEINGNHVS
     FDLMKETLRI TNLGDLKVGD WVNVERAAKF SDEIGGHLMS GHIMTTAEVA KILTSENNRQ
     IWFKVQDSQL MKYILYKGFI GIDGISLTVG EVTPTRFCVH LIPETLERTT LGKKKLGARV
     NIEIDPQTQA VVDTVERVLA ARENAMNQPG TEA
//
